XML 66 R46.htm IDEA: XBRL DOCUMENT v3.22.0.1
Shareholders' capital (Tables)
12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Schedule of Number of Common Shares
Number of common shares 
20212020
Common shares, beginning of year597,142,219 524,223,323 
Public offering67,611,465 66,130,063 
Dividend reinvestment plan6,184,686 5,217,071 
Exercise of share-based awards (c)1,020,020 1,565,537 
Conversion of convertible debentures1,886 6,225 
Common shares, end of year671,960,276 597,142,219 
Schedule of Shares Issued and Outstanding
The Company has the following preferred shares, Series A and preferred shares, Series D issued and outstanding as at December 31, 2021 and 2020:
Preferred sharesNumber of sharesPrice per shareCarrying amount C$Carrying amount $
Series A4,800,000 C$25 C$116,546 $100,463 
Series D4,000,000 C$25 C$97,259 $83,836 
$184,299 
Schedule of Share-based Compensation Expense
For the year ended December 31, 2021, AQN recorded $8,395 (2020 - $24,637) in total share-based compensation expense as follows: 
20212020
Share options$939 $1,743 
Director deferred share units821 870 
Employee share purchase592 511 
Performance and restricted share units6,043 21,513 
Total share-based compensation$8,395 $24,637 
Schedule of Fair Value of Share Options Granted
The following assumptions were used in determining the fair value of share options granted: 
20212020
Risk-free interest rate1.1 %1.2 %
Expected volatility23 %24 %
Expected dividend yield4.1 %4.1 %
Expected life5.50 years5.50 years
Weighted average grant date fair value per optionC$2.46 C$2.72 
Schedule of Stock Option Activity
Share option activity during the years is as follows: 
Number of
awards
Weighted
average
exercise
price
Weighted
average
remaining
contractual
term (years)
Aggregate
intrinsic
value
Balance, January 1, 20203,523,912 C$13.09 5.87C$18,609 
Granted999,962 16.78 7.27— 
Exercised(2,386,275)12.52 5.1618,465 
Forfeited(27,151)14.96— 
Balance, December 31, 20202,110,448 C$15.45 6.55C$11,604 
Granted437,006 19.64 7.22 
Exercised(506,926)13.92 5.951,453 
Forfeited   
Balance, December 31, 20212,040,528 C$15.45 6.11C$3,145 
Exercisable, December 31, 20211,398,668 C$16.09 5.83C$3,247 
Schedule of Performance Stock Units
A summary of the PSUs and RSUs follows: 
Number of awardsWeighted
average
grant-date
fair value
Weighted
average
remaining
contractual
term (years)
Aggregate
intrinsic
value
Balance, January 1, 20202,412,043 C$14.00 1.86C$44,309 
Granted, including dividends1,313,171 19.31 2.0024,966 
Exercised(968,470)14.45 — 20,105 
Forfeited(35,537)15.62 — 745 
Balance, December 31, 20202,721,207 C$16.58 0.93C$54,560 
Granted, including dividends805,433 19.94 2.7712,881 
Exercised(865,067)13.79  17,005 
Forfeited(217,901)18.64  3,981 
Balance, December 31, 20212,443,672 C$18.07 1.72C$44,646 
Exercisable, December 31, 2021775,674 C$16.12 C$14,172